English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The development of subclinical D.I.C. in a factor IX hemophiliac receiving concentrate replacement therapy during surgery is discussed with respect to pertinent laboratory features. The case is unique in that factor IX levels were followed carefully and corresponded inversely to the intensity of the D.I.C. Of additional significance is the failure of heparin failure given in conjunction with factor IX concentrate to prevent D.I.C. The value of adequate laboratory monitoring during factor IX replacement therapy is apparent.

Therapy with Factor IX Concentrate Resulting in D.I.C. and Thromboembolic Phenomena